AVONEX is the first treatment approved for MS patients who have their first clinical MS attack and have a brain MRI scan that suggests MS. This use was approved in Europe in 2002 and by the FDA in 2003.
Terms and Conditions of Use // Copyright © BIOGEN. Designed by Foster Design Group, Inc., and created and maintained by embarc. // Note Regarding Forward Looking Statements // Privacy Policy
